Metabolic reprogramming in the tumor microenvironment shapes immune function and therapy resistance, offering insights into ...
Morning Overview on MSN
Programmable CRISPR cuts stem cell timing from months to weeks
Programmable CRISPR tools are turning stem cell biology into something closer to software engineering, shrinking ...
In a groundbreaking study, Chinese researchers have revealed how a single plant cell can develop into a whole plant, unlocking potential applications for agriculture and crop conservation. The team ...
How do stem cells know what to become? Nearly three decades after scientists isolated the first human embryonic stem cells, researchers are still working hard to understand precisely how a single, ...
Publisher Bandai Namco and developer TYPE-MOON studio BB have delayed Fate/EXTRA full remake Fate/EXTRA Record from its previously announced 2025 release window to spring 2026 for further quality ...
A new paper in the journal Nature reveals an astonishing—and frankly unsettling—feature of some cancer cells: the ability to physically inject mitochondria into their neighboring cells. These ...
An international team led by researchers at Lund University in Sweden has identified the molecular tools needed to reprogram ordinary cells into specialised immune cells. The discovery, published in ...
According to Coherent Market Insights, the global Cell Reprogramming Market is estimated to be valued at USD 401.7 Mn in 2025 and is expected to reach USD 715.6 Mn by 2032, exhibiting a compound ...
The Edge of Fate is a title that’s perhaps a bit too on the nose for a game balanced on a blade honed by years of iteration but also worn dull by time. In the storied and rich tradition of Destiny 2, ...
Memorial Sloan Kettering Cancer Center researchers have identified a metabolic switch that determines whether intestinal stem cells become absorptive or secretory cells. Manipulating the enzyme OGDH ...
I've had a mixed experience with Fate Therapeutics, initially noting rallies but later observing a significant 75% decline, questioning market enthusiasm. Revisiting FATE after a year, I aim to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback